Which medications are both classified for the treatment of type II diabetes?

Metformin and Repaglinide are both classified as medications used to manage type II diabetes, making this choice the correct one.

Metformin is often the first-line treatment for type II diabetes, primarily working by improving insulin sensitivity and decreasing hepatic glucose production. It helps to lower blood sugar levels effectively and is well-tolerated in most patients.

Repaglinide, on the other hand, is a meglitinide class medication that stimulates insulin secretion from the pancreas. It is used to control blood sugar levels by taking it before meals to manage postprandial (after eating) hyperglycemia. The combination of Metformin and Repaglinide can provide complementary mechanisms for controlling blood sugar, with Metformin focusing on insulin sensitivity and Repaglinide enhancing insulin secretion.

Other choices include medications like statins, which are used mainly for cholesterol management and are not directly involved in the treatment of diabetes. Therefore, they do not fit the criteria of being for the treatment of type II diabetes. Understanding the role of each medication class in diabetes management is crucial for effective treatment planning.